Nutraceutical Ingredients Market

Nutraceutical Ingredients Market by Type (Proteins, Amino Acids, and Probiotics), Application (Food, Beverages, Animal Nutrition, Dietary Supplements, Food For Special Medical Purposes (FSMP)), Form, Function, & Region - Global Forecast to 2029

Report Code: FB 2211 Jul, 2024, by marketsandmarkets.com

[617 Pages Report] The global nutraceutical ingredients market size is projected to reach USD 136.1 billion by 2029 from the 2024 valuation of USD 105.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 5.3%. Urbanization and fast-paced living changed dietary preferences to convenient, on-the-go snacks and foods. According to the April 2024 article by the Food Institute, the "snackification" trend is getting stronger with more populations moving to urban centers, where commutes have become longer and workloads heavier, demanding quick and easy-to-consume food options to keep up with bussier daily schedules. The preference for smaller, more frequent meals over traditional large meals—roughly 67% of consumers worldwide make impulsive meal choices—further fuels this trend.

Artificial Intelligence (AI) is further revolutionizing the nutraceutical ingredients market by optimizing bioactive compound discovery and production, expediting R&D. For instance, in April 2023, ADM (US) and Brightseed (US) partnered to leverage AI for decoding gut microbiome interactions, using Brightseed's AI platform, Forager, to develop synbiotic products, underscoring AI's role in advancing probiotics and prebiotics for precision health solutions.

Nutraceutical Ingredients Market Size, Share

To know about the assumptions considered for the study, Request for Free Sample Report

Nutraceutical Ingredients Market Opportunities

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Drivers: Growing demand for fortified food due to increased health consciousness among consumers

The awareness of the diet–health relationship among the current consumer has seen an increase in activities like seeking of products that will offer more than the physical offering of the product. Increasingly, fortified and enriched foods with nutraceutical ingredients such as omega-3 fatty acids, antioxidants, and prebiotics now offer targeted health benefits such as heart health, immune enhancement, and improvement of digestive health. The trend is more marked in regions like North America and Europe, where wellness and preventive healthcare are really driven home. To that end, manufacturers are including these ingredients in everything from beverages and snacks to dietary supplements.

In 2022, the company performed a survey within more than 10,000 consumers across 18 countries. The research discovered that immune support remains the top health priority globally and correspondingly showed a great deal of interest in ingredients which included vitamin blends, omega-3 fatty acids and probiotics in beverages, being taken in a science-backed state. Nutritional impact and ingredient quality remain a strong focus of the consumer, who increasingly turns to personalization solutions by age and stage of life.

Product offerings that are being demanded more include weight management, heart health, muscle recovery, energy, endurance, bone health, and beauty support, among others, all in the context of nurturing bodies for long-term health and beauty goals.

Moreover, government initiatives to support health and well-being, combined with innovation in food processing technologies, continue to propel the market. All these factors together encourage the developments of new products in the nutraceutical segment to cater to the changing preferences of health-conscious consumers around the globe. Supplier and manufacturer collaborations of food products with nutraceutical ingredients are going to increase with the increasing market, bringing forward new products in the market, and this will increase the level of competition.

Restraints: Higher costs of fortified products dissuade large-scale usage and adoption

Higher costs are a key barrier to the broadening use of nutraceutical ingredients within fortified products. Such products, enriched in essential vitamins, minerals, or bioactive compounds, entail extra processing and sourcing expenses for the ingredients involved. For that matter, most consumers are particularly in lower economic areas or price-sensitive markets, buyers of such goods cannot afford to purchase them on a continuous basis. It's also difficult for manufacturing firms to increase output and stay affordable. This is due to the complex and costly process involved in sourcing and integrating quality nutraceutical ingredients. The ingredients are normally derived from natural sources, some of which are rather acquired through specialized modes of extraction, and form a big bulk of the production cost.

Moreover, regulatory and quality compliance has associated costs that increase final product prices. It is further limiting their accessibility, in particular in developing regions with high levels of malnutrition and dietary deficiency, by locking premium pricing into the market for fortified products. On the other hand, government subsidies or incentives for fortified foods and beverages could lower cost barriers such as these, yet these have been variably introduced and maintained.

Opportunities: Nutraceuticals as alternatives for pharmaceuticals

Nutraceuticals, regarded as viable alternatives to pharmaceuticals, offer substantial prospects within the nutraceutical ingredients market. The shift is brought about by an increased consumer preference for natural and preventive healthcare remedies as opposed to synthetic drugs. Vitamins, minerals, herbal extracts, and probiotics are all considered nutraceuticals. These are perceived to be safer, with fewer side effects; this perception increases their attractiveness.

With the increased cases of chronic diseases and an aging population globally, the demand for health-promoting products is surging. For instance, the World Health Organization approximates that by the year 2030, one in every six people in the world will be 60 years or older. As such, consumers are using nutraceuticals in the management of certain ailments like cardiovascular diseases, diabetes, and gastrointestinal problems. This has further pushed huge investments in R&D for innovative ingredients like plant-based compounds and bioactive peptides, thus fueling further nutraceutical ingredients market growth.

Besides, there has been a regulatory support and acknowledgment related to health benefits derived from nutraceuticals. From the product viewpoint, the regulatory bodies like FDA and EFSA have so far been successful in setting up guidelines related to health claims, motivating more companies to develop and market nutraceutical products further. In these, the role of technological development in the extraction and formulation processes has also been quite instrumental. Methods such as microencapsulation and nanotechnology increase the bioavailability and effectiveness of nutraceutical ingredients to make them competitive with pharmaceuticals.

Challenges: Combating counterfeiting and adulteration in the nutraceutical industry

Fraud and counterfeiting are very serious issues for nutraceuticals and affect market integrity and consumer confidence. Nutraceuticals have enjoyed heightened interest of late due to added health claims associated with their use, but without the tight regulative controls in force for pharmaceuticals. The lack of regulation makes the products highly prone to adulteration, counterfeiting, and diversion through complex global supply chains.

Adulteration normally involves substitution or dilution of active ingredients with a view to deceiving the customer about a product's efficacy. Several studies have found worrying levels of mislabeling, including cases in which botanicals contained cheaper substitutes or undisclosed additives, thus compromising safety and effectiveness. For instance, according to an article by Food Fraud Advisors published in 2020, a survey in the USA found that 53% of raw botanical plant parts and powders contained plant material that did not match the label. The same article noted reports of cranberry extracts adulterated with grape seed extracts and other supplements spiked with undisclosed pharmaceuticals like steroids or stimulants.

Counterfeiting aggravates the problem by creating counterfeit products that look like the originals, typically containing inferior or no active ingredients at all. Such products not only dupe consumers but also erode the goodwill and profit of genuine businesses. With growing demand for supplements that are health-enhancing, comes the challenge that originates from guaranteeing product authenticity in order to maintain customer confidence in the industry. Controls through stricter regulation and more sophisticated anti-counterfeit technologies are necessary to protect the nutraceutical marketplace from such wide-ranging and damaging fraud.

Market Ecosystem

Top Companies in Nutraceutical Ingredients Market

Proteins, By Type, Accounted for the Highest Nutraceutical Ingredients Market Share 

Proteins are important for human health in that they provide for muscle-building purposes, repair of tissues, the production of enzymes, and in the immune system. With such a high nutritional value, they are incorporated into all kinds of products: food and beverages, dietary supplements, or animal feed. According to an article by Glanbia PLC, Ireland, in December 2021, soy and dairy headed global fortification volumes. This is because they are cost-effective and available, making them nutritionally complete. From sports nutrition to infant formulas, versatility underpins soy and dairy's market leadership. Furthermore, plant-based proteins such as pea and wheat further pursue the demand for non-GMO and allergen-free options.

Consumer trends continue to amplify the demand for protein-enriched products. Flexitarianism and preference towards plant-based alternatives in North America and Europe increases the demand for plant proteins within mainstream markets. Such proteins easily attract the attention of health-conscious consumers who are after sustainability, ethics, and diversity in diet. They also find a niche in specialized nutrition products like sports nutrition and baby formulas, where proteins from dairy have a good value attached, since they are fast in absorption and build up muscularly. This segment is further supported by developments in protein fortification technologies that help manufacturers cater to different consumer needs for functional foods and customized nutrition solutions.

Dry, By Form, Accounted for the Highest Nutraceutical Ingredients Market Share And is the Fastest-Growing Market

Compared with liquids, dry forms have more significant advantages in stability and shelf-life. This stability is particularly relevant to the preservation of potency and efficacy of certain sensitive bioactive ingredients, including vitamins, minerals, and botanical extracts commonly used in nutraceutical products. Moreover, dry ingredients are also convenient to manipulate, transport, and store; hence, there are unlikely to raise any logistical complexities or costs along a supply chain. Manufacturers looking to maximise operational efficiency and reduce waste will find them especially appealing because of this.

Furthermore, dry ingredients segment finds broad applicability in a number of formats, from capsules to tablets and powdered beverages, thereby meeting these diverse ranges of consumers' preferences and consumption habits. Also, the dry segment easily caters to the growing consumer preference towards convenience and ease of use in dietary supplements and functional foods. For instance, powders and dry granules can be mixed into beverages, baked goods, and other food products without altering the texture or taste thereof to any large degree, thereby maintaining consumer acceptance.

Asia Pacific is the Fastest-Growing Market for Nutraceutical Ingredients Among the Regions

Growing health consciousness and higher disposable incomes in countries like China, India, and Japan have raised demand for functional foods and dietary supplements. Additionally, changing lifestyle due to rapid urbanization is promoting preventive measures in healthcare, which in turn increases demand for the nutraceutical ingredients market.

The growing cost of a nutritious diet exacerbates the malnutrition problem, according to an FAO article titled "Asia and the Pacific Regional Overview of Food Security and Nutrition 2023 - Statistics and Trends." According to data from the UN and FAO, the average purchasing power parity (PPP) increase in the cost of a healthy diet in the region was 5.3%, meaning that 232.8 million people could not afford it. The highest rate of undernourishment in the Asia Pacific region is found in Southern Asia, where 313.6 million people, or over 809 million people, experience moderate to severe food insecurity. This region accounts for 85 percent of all undernourished people in the region.

Nutraceutical Ingredients Market by Region

Top Nutraceutical Ingredients Companies

The nutraceutical ingredients manufacturers in this market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark).

Want to explore hidden markets that can drive new revenue in Nutraceutical Ingredients Market?

Scope of the Report

Report Metric

Details

Nutraceutical ingredients market size estimation

2024–2029

Base year considered

2023

Forecast period considered

2024–2029

Units considered

Value (USD), Volume (Kilo Ton)

Segments Covered

By Type, Application, Form, Function (Qualitative), And Region

Regions covered

North America, Europe, Asia Pacific, South America, and RoW

Nutraceutical Ingredients Companies

  • Cargill, Incorporated (US)
  • ADM (US)
  • International Flavors & Fragrances Inc. (US)
  • BASF SE (Germany)
  • Arla Foods amba (Denmark)
  • Associated British Foods plc (UK)
  • dsm-firmenich (Switzerland)
  • Ingredion (US)
  • Tate & Lyle (UK)
  • Ajinomoto Co., Inc. (Japan)
  • Chr. Hansen A/S (Denmark)
  • Kyowa Kirin Co., Ltd (Japan)
  • Glanbia PLC (Ireland)
  • Fonterra Co-Operative Group Limited (New Zealand)
  • Kerry Group plc (Ireland)
  • Divi's Laboratories Limited (India)
  • Roquette Frères (France)
  • BENEO (Germany)
  • Kemin Industries, Inc. (US)
  • Golden Grain Group Limited (China)
  • COSUCRA (Belgium)
  • Proeon (India)
  • Conagen, Inc. (US)
  • Puris (US)
  • Agrinnovation Ltd. (ChickP) (Israel)

This research report categorizes the nutraceutical ingredients market, based on type, application, form, function (qualitative), and region.

Target Audience

  • Nutraceutical ingredients Manufacturers
  • Food, Beverages, Dietary Supplement, Food for Special Medical Purposes, and Animal Nutrition Manufacturers
  • Government and regulatory bodies involved in policy-making and regulation related to nutraceuticals, functional/fortified food or feed, and dietary supplements

Report Scope:

By Function (Qualitative)
  • Additional Supplements
    • Nutrition
      • Cognitive Health
    • Weight Management
    • Skin Health
  • Medicinal Supplements
    • Gut Health
    • Heart Health
    • Bone Health
    • Immunity
    • Eye Health
    • Others
  • Sports Nutrition
By Type
  • Proteins
  • Amino Acids
    • Branched Chain Amino Acids
    • Lysine
    • Methionine
    • Threonine
    • Tryptophan
    • Other Amino Acid Types
  • Fibers & Specialty Carbohydrates
  • Probiotics
  • Phytochemicals & Plant Extracts
  • Prebiotics
  • Functional Fats & Oils
    • Conjugated Linoleic Acid
    • Medium Chain Triglycerides
    • Other Functional Fats & Oils
  • Vitamins
    • Vitamin A
    • Vitamin B
    • Vitamin C
    • Vitamin D
    • Vitamin E
    • Vitamin K
  • Minerals
  • Carotenoids
    • Lutein
    • Astaxanthin
    • Zeaxanthin
    • B-Carotene
    • Lycopene
    • Other Carotenoid Types
  • Other Types
By Application
  • Food
    • Bakery & Snacks
    • Confectionery
    • Dairy
    • Meat & Meat Products
    • Baby Food
    • Other Food Products
  • Beverages
    • Energy Drinks
    • Juices
    • Health Drinks
  • Animal Nutrition
  • Dietary Supplements
  • Foods For Special Medical Purposes (FSMP)
By Form
  • Dry
  • Liquid
By Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Rest of the World (RoW)

Recent Developments

  • In June 2024, Ingredion (US) and Univar Solutions Inc. (US) expanded their long-term partnership to distribute Ingredion's functional food and beverage ingredients in Germany, Italy, and Switzerland. This collaboration, focusing on starches, plant-based proteins, and stevia sweeteners, aims to meet the increasing demand for healthier, sustainable, and flavor-rich products. The partnership leverages Univar Solutions Inc.’s extensive commercial reach and Ingredion's innovative ingredient portfolio to enhance product performance and market responsiveness. This expansion into key European markets helps Ingredion strengthen its presence in the European nutraceutical ingredients market.
  • In December 2023, ADM (US announced an agreement to acquire UK-based FDL Ltd, a leading company in premium flavor and functional ingredient systems, to enhance its global flavors and functional ingredients capabilities. FDL Ltd, with projected 2023 sales of USD 120 million and a strong presence in the European food service segment, operates three production facilities and two innovation centers in the UK. This acquisition adds FDL Ltd's extensive innovation expertise and diverse portfolio of functional ingredients (such as amino acids) and proprietary flavor formulations to ADM's offerings.
  • In October 2023, Arla Foods amba (Denmark) invested to significantly upgrade its Porteña facility in Argentina, to double its whey permeate powder capacity and enable the production of infant formula-grade proteins. This expansion includes a new drying tower and enhanced sanitary measures, aligning with global demand, especially in Asia and Latin America. Dairy technology provider RELCO will construct the new tower, set to be operational by 2026. The expansion supports Arla Foods amba's growth in the nutraceutical ingredients market by increasing the supply of high-quality, specialized ingredients for food and beverage applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 51)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 INCLUSIONS & EXCLUSIONS
           1.3.3 YEARS CONSIDERED
    1.4 UNIT CONSIDERED 
           1.4.1 CURRENCY CONSIDERED
           1.4.2 VOLUME UNIT CONSIDERED
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 59)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key insights from industry experts
                    2.1.2.3 Breakdown of primary interviews
    2.2 NUTRACEUTICAL INGREDIENTS MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
           2.2.3 SUPPLY-SIDE ANALYSIS
           2.2.4 DEMAND-SIDE ANALYSIS
    2.3 DATA TRIANGULATION 
    2.4 RESEARCH ASSUMPTIONS 
    2.5 LIMITATIONS AND RISK ASSESSMENT 
 
3 EXECUTIVE SUMMARY (Page No. - 71)
 
4 PREMIUM INSIGHTS (Page No. - 78)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET 
    4.2 ASIA PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY 
    4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SNAPSHOT 
    4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION 
    4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION AND REGION 
    4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM AND REGION 
 
5 MARKET OVERVIEW (Page No. - 83)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 DEVELOPMENTS IN RETAIL INDUSTRY
           5.2.2 RISE IN NUMBER OF DUAL-INCOME HOUSEHOLDS
    5.3 MARKET DYNAMICS 
           5.3.1 DRIVERS
                    5.3.1.1 Growing demand for fortified food due to increased health consciousness
                    5.3.1.2 Rising incidences of chronic diseases
                    5.3.1.3 Mandates on food fortification by government organizations
                    5.3.1.4 Rise in awareness about feed quality
                    5.3.1.5 Increase in personalized nutrition trends
                    5.3.1.6 Rise in digital health platforms and wearable & implantable technologies
           5.3.2 RESTRAINTS
                    5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Rising use of nutraceuticals as alternatives for pharmaceuticals
                    5.3.3.2 Alternative sources to obtain functional fats & oils
           5.3.4 CHALLENGES
                    5.3.4.1 Proliferation of counterfeit products
                    5.3.4.2 Lack of consistency in regulations pertaining to various ingredients
 
6 INDUSTRY TRENDS (Page No. - 100)
    6.1 INTRODUCTION 
    6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    6.3 PRICING ANALYSIS 
           6.3.1 AVERAGE SELLING PRICE TREND, BY TYPE
           6.3.2 AVERAGE SELLING PRICE TREND, BY REGION
    6.4 VALUE CHAIN ANALYSIS 
           6.4.1 RAW MATERIAL SOURCING
           6.4.2 PRODUCTION & PROCESSING
           6.4.3 DISTRIBUTION
           6.4.4 END USERS
    6.5 ECOSYSTEM 
           6.5.1 DEMAND SIDE
                    6.5.1.1 Ingredient manufacturers
                    6.5.1.2 Technology providers
                    6.5.1.3 Start-ups/emerging companies
           6.5.2 SUPPLY SIDE
                    6.5.2.1 Regulatory bodies
                    6.5.2.2 End users
    6.6 TECHNOLOGY ANALYSIS 
           6.6.1 KEY TECHNOLOGIES
                    6.6.1.1 CRISPR and gene editing
           6.6.2 COMPLEMENTARY TECHNOLOGIES
                    6.6.2.1 Microencapsulated powder for probiotic action in food products
                    6.6.2.2 Robotics leading to innovations in market
                    6.6.2.3 Hologram sciences—platform for personalized nutrition and advice
           6.6.3 ADJACENT TECHNOLOGIES
                    6.6.3.1 3D printing
    6.7 PATENT ANALYSIS 
    6.8 TRADE ANALYSIS 
           6.8.1 EXPORT SCENARIO OF NUTRACEUTICAL INGREDIENTS
                    6.8.1.1 Import scenario of nutraceutical ingredients
    6.9 KEY CONFERENCES AND EVENTS, 2024–2025 
    6.1 TARIFF AND REGULATORY LANDSCAPE 
           6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.10.2 REGULATORY FRAMEWORK
                    6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market
                    6.10.2.2 North America
                               6.10.2.2.1 Canada
                               6.10.2.2.2 US
                               6.10.2.2.3 Mexico
                    6.10.2.3 European Union (EU)
                    6.10.2.4 Asia Pacific
                               6.10.2.4.1 Japan
                               6.10.2.4.2 China
                               6.10.2.4.3 India
                               6.10.2.4.4 Australia & New Zealand
                    6.10.2.5 Rest of the World (RoW)
                               6.10.2.5.1 Brazil
                    6.10.2.6 Probiotics
                               6.10.2.6.1 Introduction
                               6.10.2.6.2 National/International bodies for safety standards and regulations
                               6.10.2.6.3 North America: Regulatory environment analysis
                               6.10.2.6.4 Europe: Regulatory environment analysis
                               6.10.2.6.5 Asia Pacific: Regulatory environment analysis
                               6.10.2.6.6 South America: Regulatory environment analysis
                    6.10.2.7 Prebiotics
                               6.10.2.7.1 Introduction
                               6.10.2.7.2 Asia Pacific
                               6.10.2.7.3 North America
                               6.10.2.7.4 European Union
    6.11 PORTER'S FIVE FORCES ANALYSIS 
           6.11.1 INTENSITY OF COMPETITIVE RIVALRY
           6.11.2 THREAT OF NEW ENTRANTS
           6.11.3 THREAT OF SUBSTITUTES
           6.11.4 BARGAINING POWER OF SUPPLIERS
           6.11.5 BARGAINING POWER OF BUYERS
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
           6.12.2 BUYING CRITERIA
    6.13 CASE STUDY ANALYSIS 
           6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
           6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH EVALUATED PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING
           6.13.3 ROQUETTE FRÈRES ACHIEVED COMPLETE AMINO ACID PROFILE WITH NUTRALYS PEA PROTEIN
    6.14 INVESTMENT AND FUNDING SCENARIO 
    6.15 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES 
           6.15.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
           6.15.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
                    6.15.2.1 Flavor and ingredient innovation
                    6.15.2.2 AI-enabled digital tools for consumer understanding and product development
                    6.15.2.3 Personalized AI-developed nutrition platform
                    6.15.2.4 AI and cloud technology to address challenges in F&B industry
           6.15.3 IMPACT OF GENERATIVE AI/AI ON NUTRACEUTICAL INGREDIENTS MARKET
           6.15.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI
 
7 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE (Page No. - 147)
    7.1 INTRODUCTION 
    7.2 PROTEINS 
    7.3 AMINO ACIDS 
           7.3.1 BRANCHED CHAIN AMINO ACIDS
                    7.3.1.1 Leucine
                    7.3.1.2 Isoleucine
                    7.3.1.3 Valine
           7.3.2 LYSINE
           7.3.3 METHIONINE
           7.3.4 THREONINE
           7.3.5 TRYPTOPHAN
           7.3.6 GLUTAMIC ACID
           7.3.7 PHENYLALANINE
           7.3.8 OTHER AMINO ACID TYPES
    7.4 FIBERS & SPECIALTY CARBOHYDRATES 
    7.5 PROBIOTICS 
    7.6 PHYTOCHEMICALS & PLANT EXTRACTS 
    7.7 PREBIOTICS 
    7.8 FUNCTIONAL FATS & OILS 
           7.8.1 POLYUNSATURATED FATTY ACIDS (PUFAS)
                    7.8.1.1 Omega-3 fatty acids
                    7.8.1.2 Omega-6 fatty acids
                    7.8.1.3 Conjugated Linoleic Acid (CLA)
           7.8.2 OMEGA-9 FATTY ACIDS
           7.8.3 MEDIUM CHAIN TRIGLYCERIDES
           7.8.4 OTHER FUNCTIONAL FATS & OILS
    7.9 VITAMINS 
           7.9.1 VITAMIN A
           7.9.2 VITAMIN B
           7.9.3 VITAMIN C
           7.9.4 VITAMIN D
           7.9.5 VITAMIN E
           7.9.6 VITAMIN K
    7.1 MINERALS 
    7.11 CAROTENOIDS 
           7.11.1 LUTEIN
           7.11.2 ASTAXANTHIN
           7.11.3 ZEAXANTHIN
           7.11.4 B-CAROTENE
           7.11.5 LYCOPENE
           7.11.6 OTHER CAROTENOIDS
    7.12 OTHER TYPES 
 
8 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION (Page No. - 219)
    8.1 INTRODUCTION 
    8.2 FOOD 
           8.2.1 TECHNOLOGICAL ADVANCEMENTS IN FOOD PROCESSING EQUIPMENT, HIGH HEALTHCARE COSTS, AND INCREASED INCIDENCES OF CHRONIC DISEASE TO DRIVE MARKET
           8.2.2 BAKERY & SNACKS
           8.2.3 CONFECTIONERY
           8.2.4 DAIRY
           8.2.5 MEAT & MEAT PRODUCTS
           8.2.6 BABY FOOD
           8.2.7 OTHER FOOD PRODUCTS
    8.3 BEVERAGES 
           8.3.1 RISING HEALTH-CONSCIOUSNESS, HECTIC LIFESTYLES OF WORKING POPULATION, AND GROWING INCLINATION TOWARD HEALTHY BEVERAGES TO PROPEL MARKET
           8.3.2 ENERGY DRINKS
           8.3.3 JUICES
           8.3.4 HEALTH DRINKS
    8.4 ANIMAL NUTRITION 
           8.4.1 INCREASE IN DEMAND FOR ANIMAL HEALTH AND NUTRITION TO FUEL DEMAND FOR NUTRACEUTICAL INGREDIENTS IN ANIMAL NUTRITION
           8.4.2 AMINO ACID IN ANIMAL NUTRITION
    8.5 DIETARY SUPPLEMENTS 
           8.5.1 CONSUMER AWARENESS AND GROWING INCLINATION TOWARD INITIATIVE-TAKING HEALTH MANAGEMENT TO FOSTER NUTRACEUTICAL INGREDIENTS MARKET GROWTH
    8.6 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP) 
           8.6.1 ADVANCEMENTS IN MEDICAL RESEARCH, INCREASING AWARENESS ABOUT CLINICAL NUTRITION, AND CONTINUOUS EMERGENCE OF NEW MEDICAL CONDITIONS TO BOOST NUTRACEUTICAL INGREDIENTS MARKET GROWTH
 
9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM (Page No. - 236)
    9.1 INTRODUCTION 
    9.2 DRY 
           9.2.1 SUPERIOR STABILITY, CONVENIENT HANDLING, AND LONGER SHELF-LIFE TO FUEL DEMAND FOR DRY FORM OF INGREDIENTS
    9.3 LIQUID 
           9.3.1 EASE OF CONSUMPTION AND FASTER ABSORPTION RATES TO FOSTER DEMAND FOR LIQUID FORM OF INGREDIENTS
 
10 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION (Page No. - 241)
     10.1 INTRODUCTION 
     10.2 ADDITIONAL SUPPLEMENTS 
             10.2.1 NEED TO ADDRESS SPECIFIC DEFICIENCIES, MANAGE HEALTH CONDITIONS, AND ENHANCE PHYSICAL APPEARANCE TO BOOST NUTRACEUTICAL INGREDIENTS MARKET GROWTH
             10.2.2 NUTRITION
             10.2.3 WEIGHT MANAGEMENT
             10.2.4 SKIN HEALTH
     10.3 MEDICINAL SUPPLEMENTS 
             10.3.1 INCREASING CONSUMER AWARENESS ABOUT PREVENTIVE HEALTHCARE AND RISING INCIDENCES OF LIFESTYLE-RELATED DISEASES TO DRIVE MARKET
             10.3.2 GUT HEALTH
             10.3.3 HEART HEALTH
             10.3.4 BONE HEALTH
             10.3.5 IMMUNITY
             10.3.6 EYE HEALTH
             10.3.7 OTHER MEDICAL SUPPLEMENTS
     10.4 SPORTS NUTRITION 
             10.4.1 INCREASED NUTRIENT REQUIREMENTS DUE TO DEMANDING PHYSICAL ACTIVITIES TO DRIVE DEMAND
 
11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION (Page No. - 252)
     11.1 INTRODUCTION 
     11.2 NORTH AMERICA 
             11.2.1 US
                       11.2.1.1 Increased consumer demand for fortified food & beverages and rising healthcare costs to drive market
             11.2.2 CANADA
                       11.2.2.1 High prevalence of inadequate vitamin D and calcium levels, rising food industry, and growing consumer health awareness to propel market
             11.2.3 MEXICO
                       11.2.3.1 Rise in per capita expenditure on nutritious and healthy foods to fuel demand for nutraceutical ingredients
     11.3 EUROPE 
             11.3.1 GERMANY
                       11.3.1.1 Growing dietary supplement industry and focus on functional foods to address health concerns to boost nutraceutical ingredients market growth
             11.3.2 UK
                       11.3.2.1 Rising awareness regarding healthy diet and increasing demand for dietary ingredients to drive market
             11.3.3 FRANCE
                       11.3.3.1 Increased health awareness and strategic government initiatives to foster market
             11.3.4 ITALY
                       11.3.4.1 High consumption of food supplements and functional foods, widespread acceptance of probiotic products, and rising awareness of associated health benefits to accelerate nutraceutical ingredients market growth
             11.3.5 SPAIN
                       11.3.5.1 Increased pork production to drive nutraceutical ingredients market growth
             11.3.6 REST OF EUROPE
     11.4 ASIA PACIFIC 
             11.4.1 CHINA
                       11.4.1.1 Growing ‘punk nutrition’ trend coupled with changing lifestyles to progress nutraceutical ingredients market growth
             11.4.2 INDIA
                       11.4.2.1 Emphasis on preventive healthcare due to rising hospitalization costs to foster nutraceutical ingredients market growth
             11.4.3 JAPAN
                       11.4.3.1 Weather conditions being suitable for microbial growth and focus on fortified foods to boost nutraceutical ingredients market growth
             11.4.4 AUSTRALIA & NEW ZEALAND
                       11.4.4.1 Changing lifestyles, increased purchasing power, and rising spending on nutritional foods to accelerate nutraceutical ingredients market growth
             11.4.5 REST OF ASIA PACIFIC
     11.5 SOUTH AMERICA 
             11.5.1 BRAZIL
                       11.5.1.1 Improved health consciousness, growing urbanization, health consciousness, and escalating obesity rates to propel market
             11.5.2 ARGENTINA
                       11.5.2.1 Prevalence of malnutrition and need for nutritious diet to drive nutraceutical ingredients market growth
             11.5.3 REST OF SOUTH AMERICA
     11.6 REST OF THE WORLD (ROW) 
             11.6.1 MIDDLE EAST
                       11.6.1.1 Increased demand for healthy food amid rising health concerns to foster nutraceutical ingredients market growth
             11.6.2 AFRICA
                       11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals to boost nutraceutical ingredients market growth
 
12 COMPETITIVE LANDSCAPE (Page No. - 434)
     12.1 OVERVIEW 
     12.2 KEY NUTRACEUTICAL INGREDIENTS COMPANIES STRATEGIES/RIGHT TO WIN 
     12.3 REVENUE ANALYSIS 
     12.4 NUTRACEUTICAL INGREDIENTS MARKET SHARE ANALYSIS, 2023 
             12.4.1 MARKET RANKING ANALYSIS
     12.5 COMPANY EVALUATION MATRIX: KEY NUTRACEUTICAL INGREDIENTS COMPANIES, 2023 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
             12.5.5 COMPANY FOOTPRINT: KEY NUTRACEUTICAL INGREDIENTS COMPANIES , 2023
                       12.5.5.1 Company footprint
                       12.5.5.2 Regional footprint
                       12.5.5.3 Type footprint
                       12.5.5.4 Application footprint
                       12.5.5.5 Form footprint
     12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
             12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
                       12.6.5.1 Key start-ups/SMEs
                       12.6.5.2 Competitive benchmarking of key start-ups/SMEs
     12.7 COMPANY VALUATION AND FINANCIAL METRICS 
     12.8 BRAND/PRODUCT COMPARISON 
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
             12.9.2 DEALS
             12.9.3 EXPANSIONS
             12.9.4 OTHER DEALS/DEVELOPMENTS
 
13 COMPANY PROFILES (Page No. - 486)
     13.1 KEY NUTRACEUTICAL INGREDIENTS COMPANIES 
             13.1.1 CARGILL, INCORPORATED
                       13.1.1.1 Business overview
                       13.1.1.2 Products/Solutions/Services offered
                       13.1.1.3 Recent developments
                                   13.1.1.3.1 Deals
                                   13.1.1.3.2 Other deals/developments
                       13.1.1.4 MnM view
                                   13.1.1.4.1 Right to win
                                   13.1.1.4.2 Strategic choices made
                                   13.1.1.4.3 Weaknesses and competitive threats
             13.1.2 ADM
                       13.1.2.1 Business overview
                       13.1.2.2 Products/Solutions/Services offered
                       13.1.2.3 Recent developments
                                   13.1.2.3.1 Product launches
                                   13.1.2.3.2 Deals
                                   13.1.2.3.3 Other deals/developments
                       13.1.2.4 MnM view
                                   13.1.2.4.1 Right to win
                                   13.1.2.4.2 Strategic choices made
                                   13.1.2.4.3 Weaknesses and competitive threats
             13.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC.
                       13.1.3.1 Business overview
                       13.1.3.2 Products/Solutions/Services offered
                       13.1.3.3 Recent developments
                                   13.1.3.3.1 Product launches
                                   13.1.3.3.2 Deals
                                   13.1.3.3.3 Other deals/developments
                       13.1.3.4 MnM view
                                   13.1.3.4.1 Right to win
                                   13.1.3.4.2 Strategic choices made
                                   13.1.3.4.3 Weaknesses and competitive threats
             13.1.4 BASF SE
                       13.1.4.1 Business overview
                       13.1.4.2 Products/Solutions/Services offered
                       13.1.4.3 Recent developments
                                   13.1.4.3.1 Product launches and enhancements
                                   13.1.4.3.2 Deals
                                   13.1.4.3.3 Other deals/developments
                       13.1.4.4 MnM view
                                   13.1.4.4.1 Right to win
                                   13.1.4.4.2 Strategic choices made
                                   13.1.4.4.3 Weaknesses and competitive threats
             13.1.5 ARLA FOODS AMBA
                       13.1.5.1 Business overview
                       13.1.5.2 Products/Solutions/Services offered
                       13.1.5.3 Recent developments
                                   13.1.5.3.1 Product launches
                                   13.1.5.3.2 Deals
                                   13.1.5.3.3 Other deals/developments
                       13.1.5.4 MnM view
                                   13.1.5.4.1 Right to win
                                   13.1.5.4.2 Strategic choices made
                                   13.1.5.4.3 Weaknesses and competitive threats
             13.1.6 DSM-FIRMENICH
                       13.1.6.1 Business overview
                       13.1.6.2 Products/Solutions/Services offered
                       13.1.6.3 Recent developments
                                   13.1.6.3.1 Product launches
                                   13.1.6.3.2 Deals
                       13.1.6.4 MnM view
             13.1.7 INGREDION
                       13.1.7.1 Business overview
                       13.1.7.2 Products/Solutions/Services offered
                       13.1.7.3 Recent developments
                                   13.1.7.3.1 Product launches
                                   13.1.7.3.2 Deals
                                   13.1.7.3.3 Other deals/developments
                       13.1.7.4 MnM view
             13.1.8 TATE & LYLE
                       13.1.8.1 Business overview
                       13.1.8.2 Products/Solutions/Services offered
                       13.1.8.3 Recent developments
                                   13.1.8.3.1 Product launches
                                   13.1.8.3.2 Deals
                                   13.1.8.3.3 Other deals/developments
                       13.1.8.4 MnM view
             13.1.9 AJINOMOTO CO., INC.
                       13.1.9.1 Business overview
                       13.1.9.2 Products/Solutions/Services offered
                       13.1.9.3 Recent developments
                                   13.1.9.3.1 Deals
                                   13.1.9.3.2 Other deals/developments
                       13.1.9.4 MnM view
               13.1.10 ASSOCIATED BRITISH FOODS PLC
            13.1.10.1 Business overview
            13.1.10.2 Products/Solutions/Services offered
            13.1.10.3 Recent developments
                     13.1.10.3.1 Deals
            13.1.10.4 MnM view
               13.1.11 CHR. HANSEN A/S
            13.1.11.1 Business overview
            13.1.11.2 Products/Solutions/Services offered
            13.1.11.3 Recent developments
                     13.1.11.3.1 Product launches and enhancements
                     13.1.11.3.2 Deals
                     13.1.11.3.3 Other deals/developments
            13.1.11.4 MnM view
               13.1.12 KYOWA KIRIN CO., LTD
            13.1.12.1 Business overview
            13.1.12.2 Products/Solutions/Services offered
            13.1.12.3 Recent developments
            13.1.12.4 MnM view
               13.1.13 GLANBIA PLC
            13.1.13.1 Business overview
            13.1.13.2 Products/Solutions/Services offered
            13.1.13.3 Recent developments
                     13.1.13.3.1 Product launches
                     13.1.13.3.2 Deals
                     13.1.13.3.3 Other deals/developments
            13.1.13.4 MnM view
               13.1.14 FONTERRA CO-OPERATIVE GROUP LIMITED
            13.1.14.1 Business overview
            13.1.14.2 Products/Solutions/Services offered
            13.1.14.3 Recent developments
                     13.1.14.3.1 Deals
            13.1.14.4 MnM view
               13.1.15 KERRY GROUP PLC
            13.1.15.1 Business overview
            13.1.15.2 Products/Solutions/Services offered
            13.1.15.3 Recent developments
                     13.1.15.3.1 Product launches
                     13.1.15.3.2 Deals
                     13.1.15.3.3 Other deals/developments
            13.1.15.4 MnM view
     13.2 OTHER PLAYERS 
             13.2.1 DIVI'S LABORATORIES LIMITED
                       13.2.1.1 Business overview
                       13.2.1.2 Products/Solutions/Services offered
                       13.2.1.3 Recent developments
                                   13.2.1.3.1 Product launches
                       13.2.1.4 MnM view
             13.2.2 ROQUETTE FRÈRES
                       13.2.2.1 Business overview
                       13.2.2.2 Products/Solutions/Services offered
                       13.2.2.3 Recent developments
                                   13.2.2.3.1 Product launches and enhancements
                                   13.2.2.3.2 Other deals/developments
                       13.2.2.4 MnM view
             13.2.3 BENEO
                       13.2.3.1 Business overview
                       13.2.3.2 Products/Solutions/Services offered
                       13.2.3.3 Recent developments
                                   13.2.3.3.1 Other deals/developments
                       13.2.3.4 MnM view
             13.2.4 KEMIN INDUSTRIES, INC.
                       13.2.4.1 Business overview
                       13.2.4.2 Products/Solutions/Services offered
                       13.2.4.3 Recent developments
                                   13.2.4.3.1 Product enhancements
                                   13.2.4.3.2 Other deals/developments
                       13.2.4.4 MnM view
             13.2.5 GOLDEN GRAIN GROUP LIMITED
                       13.2.5.1 Business overview
                       13.2.5.2 Products/Solutions/Services offered
                       13.2.5.3 Recent developments
                       13.2.5.4 MnM view
             13.2.6 COSUCRA
             13.2.7 PURIS
             13.2.8 PROEON
             13.2.9 CONAGEN, INC.
               13.2.10 CHICKP
 
14 ADJACENT & RELATED MARKETS (Page No. - 601)
     14.1 INTRODUCTION 
     14.2 RESEARCH LIMITATIONS 
     14.3 DIETARY SUPPLEMENTS MARKET 
             14.3.1 MARKET DEFINITION
             14.3.2 MARKET OVERVIEW
             14.3.3 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER
             14.3.4 DIETARY SUPPLEMENTS MARKET, BY REGION
     14.4 HEALTH INGREDIENTS MARKET 
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
             14.4.3 HEALTH INGREDIENTS MARKET, BY SOURCE
             14.4.4 HEALTH INGREDIENTS MARKET, BY REGION
 
15 APPENDIX (Page No. - 607)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (706 Tables)  
 
TABLE 1 USD EXCHANGE RATES, 2020–2023 
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION) 
TABLE 3 GLOBAL PREVALENCE OF ANEMIA ACROSS DIFFERENT POPULATION GROUPS, 2019 
TABLE 4 WIDELY USED FORTIFIED FOODS 
TABLE 5 PERSONALIZED NUTRITION TRENDS AND ADVANCEMENTS 
TABLE 6 EXAMPLES OF UNITED STATES FDA-APPROVED MEDICAL WEARABLE AND IMPLANTABLE DEVICES 
TABLE 7 HEALTH ISSUES AND NUTRACEUTICAL INGREDIENTS USED FOR CURE 
TABLE 8 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 
TABLE 9 AVERAGE SELLING PRICES OF TOP THREE TYPES, 2020–2023 (USD/KG) 
TABLE 10 AVERAGE SELLING PRICE TRENDS, BY REGION, 2020–2023 (USD/KG) 
TABLE 11 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM 
TABLE 12 LIST OF MAJOR PATENTS PERTAINING TO NUTRACEUTICAL INGREDIENTS MARKET, 2014-2024 
TABLE 13 TOP FIVE EXPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936), 2023 (USD THOUSAND) 
TABLE 14 TOP FIVE IMPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936), 2023 (USD THOUSAND) 
TABLE 15 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025 
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
TABLE 20 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
TABLE 21 DEFINITIONS AND REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE 
TABLE 22 REGULATORY ORGANIZATIONS FOR NUTRACEUTICALS INGREDIENTS WORLDWIDE 
TABLE 23 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015 
TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES AND THEIR SOURCES 
TABLE 25 PORTER'S FIVE FORCES IMPACT ON NUTRACEUTICAL INGREDIENTS MARKET 
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES 
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE TYPES 
TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 32 RECOMMENDED DIETARY ALLOWANCES (RDA) FOR PROTEINS IN DIFFERENT AGE GROUPS (GRAMS/DAY) 
TABLE 33 FUNCTIONS OF PROTEIN 
TABLE 34 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 35 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 36 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 37 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 38 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 39 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 40 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 41 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 43 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 44 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 45 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 46 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2020–2023 (USD MILLION) 
TABLE 47 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2024–2029 (USD MILLION) 
TABLE 48 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 49 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 50 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 51 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 52 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 53 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 54 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 55 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 56 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 57 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 58 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 59 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 60 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 61 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 62 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 63 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 64 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 65 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 66 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 67 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 68 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 69 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 70 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 71 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 72 PROBIOTIC COMPONENTS & THEIR BENEFITS 
TABLE 73 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 74 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 75 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 76 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 77 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS 
TABLE 78 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 79 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 80 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 81 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 82 PREBIOTIC COMPONENTS & THEIR BENEFITS 
TABLE 83 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 84 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 85 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 86 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 87 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 88 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 89 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 90 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 93 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 94 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 95 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2020–2023 (USD MILLION) 
TABLE 96 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2024–2029 (USD MILLION) 
TABLE 97 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 98 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 99 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 100 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 101 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 102 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 103 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 104 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 105 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 106 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 107 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 108 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 109 VITAMINS CLASSIFIED AS MICRONUTRIENTS 
TABLE 110 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 111 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 112 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 113 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 114 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 115 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 116 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 117 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 118 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 119 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 120 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 121 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 122 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 123 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 124 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 125 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 126 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 127 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 128 MACROMINERALS & THEIR FUNCTIONS 
TABLE 129 MICROMINERALS & THEIR FUNCTIONS 
TABLE 130 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 131 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 132 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 133 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 134 SOURCES OF CAROTENOIDS IN FRUITS AND VEGETABLES AND THEIR MEDICINAL PROPERTIES 
TABLE 135 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 136 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 137 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 138 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 139 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 140 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 141 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 142 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 143 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 144 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 145 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 146 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 147 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 148 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 149 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 150 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 151 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 152 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 153 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 154 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 155 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 156 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 157 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 158 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 159 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 160 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 161 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS 
TABLE 162 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS 
TABLE 163 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 164 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 165 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 166 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 167 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 168 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 169 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 170 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 171 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 172 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 173 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 174 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 175 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 176 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 177 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE 
TABLE 178 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 
TABLE 179 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 
TABLE 180 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (KILO TON) 
TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (KILO TON) 
TABLE 182 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 
TABLE 183 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 
TABLE 184 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 185 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 186 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 187 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 188 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 189 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 190 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 191 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 192 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 193 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 194 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 195 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 196 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 197 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 198 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 199 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 200 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 201 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 202 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 203 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 204 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 205 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 206 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 207 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 208 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 209 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 210 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 211 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 212 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 213 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 214 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 215 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 216 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 217 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 218 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 219 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 220 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 221 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 222 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 223 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 224 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 225 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 226 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 227 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 228 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 229 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 230 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 231 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 232 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 233 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 234 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 235 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 236 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 237 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 238 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 239 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 240 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 241 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 242 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 243 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 244 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 245 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 246 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 247 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 248 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 249 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 250 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 251 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 252 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 
TABLE 253 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 
TABLE 254 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 255 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 256 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 257 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 258 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 259 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 260 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 261 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 262 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 263 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 264 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 265 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 266 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 267 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 268 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 269 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 270 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 271 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 272 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 273 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 274 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 275 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 276 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 277 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 278 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 279 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 280 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 281 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 282 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 283 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 284 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 285 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 286 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 287 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 288 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 289 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 290 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 291 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 292 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 293 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 294 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN  
TABLE 295 306 
TABLE 296 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 297 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 298 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 299 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 300 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 301 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 302 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 303 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 304 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 305 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 306 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 307 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 308 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 309 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 310 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 311 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 312 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 313 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 314 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 315 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 316 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 317 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 318 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 319 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 320 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 321 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 322 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 323 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 324 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 325 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 326 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 327 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 328 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 329 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 330 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 331 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 332 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 333 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 334 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 335 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 336 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 337 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 338 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 339 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 340 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 341 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 342 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 343 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 344 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 345 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 346 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 347 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 348 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 349 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 350 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 351 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 352 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 353 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 354 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 355 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 356 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 357 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 358 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 359 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 360 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 361 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 362 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 363 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 364 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 365 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 366 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 367 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 368 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 369 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 370 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 371 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 
TABLE 372 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 
TABLE 373 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 374 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 375 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 376 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 377 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 378 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 379 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 380 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 381 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 382 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 383 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 384 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 385 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 386 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 387 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 388 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 389 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 390 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 391 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 392 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 393 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 394 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 395 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 396 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 397 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 398 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 399 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 400 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 401 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 402 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 403 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 404 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 405 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 406 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 407 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 408 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 409 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 410 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 411 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 412 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 413 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 414 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 415 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 416 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 417 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 418 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 419 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 420 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 421 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 422 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 423 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 424 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 425 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 426 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 427 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 428 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 429 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 430 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 431 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 432 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 433 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 434 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 435 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 436 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 437 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 438 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 439 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 440 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 441 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 442 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 443 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 444 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 445 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 446 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 447 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 448 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 449 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 450 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 451 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 452 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 453 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 454 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 455 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 456 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 457 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 458 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 459 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 460 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 461 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 462 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 463 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 464 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 465 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 466 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 467 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 468 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 469 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 470 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 471 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 472 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 473 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 
TABLE 474 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 
TABLE 475 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 476 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 477 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 478 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 479 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 480 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 481 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 482 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 483 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 484 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 485 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 486 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 487 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 488 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 489 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 490 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 491 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 492 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 493 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 494 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 495 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 496 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 497 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 498 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 499 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 500 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 501 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 502 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 503 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 504 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 505 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 506 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 507 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 508 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 509 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 510 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 511 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 512 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 513 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 514 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 515 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 516 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 517 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 518 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 519 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 520 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 521 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 522 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 523 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 524 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 525 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 526 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 527 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 528 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 529 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 530 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 531 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 532 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 533 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 534 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 535 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 536 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 537 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 538 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 539 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 540 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 541 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 542 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 543 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2020–2023 (USD MILLION) 
TABLE 544 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2024–2029 (USD MILLION) 
TABLE 545 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 546 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 547 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON) 
TABLE 548 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON) 
TABLE 549 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 550 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 551 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 552 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 553 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 554 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 555 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 556 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 557 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 558 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 559 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 560 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 561 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 562 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 563 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION) 
TABLE 564 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION) 
TABLE 565 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 566 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 567 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 568 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 569 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 570 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 571 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 572 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 573 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 574 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 575 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 576 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 577 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 578 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 579 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 580 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 581 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 
TABLE 582 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 
TABLE 583 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 584 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 585 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION) 
TABLE 586 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION) 
TABLE 587 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION) 
TABLE 588 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION) 
TABLE 589 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION) 
TABLE 590 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION) 
TABLE 591 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION) 
TABLE 592 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION) 
TABLE 593 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION) 
TABLE 594 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION) 
TABLE 595 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 
TABLE 596 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 
TABLE 597 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS VENDORS 
TABLE 598 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION 
TABLE 599 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL FOOTPRINT 
TABLE 600 NUTRACEUTICAL INGREDIENTS MARKET: TYPE FOOTPRINT 
TABLE 601 NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT 
TABLE 602 NUTRACEUTICAL INGREDIENTS MARKET: FORM FOOTPRINT 
TABLE 603 NUTRACEUTICAL INGREDIENTS MARKET: KEY START-UPS/SMES 
TABLE 604 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES, 2023 
TABLE 605 NUTRACEUTICAL INGREDIENTS MARKET: PRODUCT LAUNCHES AND ENHANCEMENTS, MARCH 2020–MAY 2024 
TABLE 606 NUTRACEUTICAL INGREDIENTS MARKET: DEALS, JANUARY 2020–JUNE 2024 
TABLE 607 NUTRACEUTICAL INGREDIENTS MARKET: EXPANSIONS, MARCH 2020–MAY 2024 
TABLE 608 NUTRACEUTICAL INGREDIENTS MARKET: OTHER DEALS/DEVELOPMENTS, JANUARY 2021–JANUARY 2024 
TABLE 609 CARGILL, INCORPORATED: COMPANY OVERVIEW 
TABLE 610 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 611 CARGILL, INCORPORATED: DEALS 
TABLE 612 CARGILL, INCORPORATED: EXPANSIONS 
TABLE 613 CARGILL, INCORPORATED: OTHER DEALS/DEVELOPMENTS 
TABLE 614 ADM: COMPANY OVERVIEW 
TABLE 615 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 616 ADM: PRODUCT LAUNCHES 
TABLE 617 ADM: DEALS 
TABLE 618 ADM: EXPANSIONS 
TABLE 619 ADM: OTHER DEALS/DEVELOPMENTS 
TABLE 620 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW 
TABLE 621 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 622 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES 
TABLE 623 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 
TABLE 624 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS 
TABLE 625 BASF SE: COMPANY OVERVIEW 
TABLE 626 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 627 BASF SE: PRODUCT LAUNCHES AND ENHANCEMENTS 
TABLE 628 BASF SE: DEALS 
TABLE 629 BASF SE: EXPANSIONS 
TABLE 630 BASF SE: OTHER DEALS/DEVELOPMENTS 
TABLE 631 ARLA FOODS AMBA: COMPANY OVERVIEW 
TABLE 632 ARLA FOODS AMBA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 633 ARLA FOODS AMBA: PRODUCT LAUNCHES 
TABLE 634 ARLA FOODS AMBA: DEALS 
TABLE 635 ARLA FOODS AMBA: EXPANSIONS 
TABLE 636 DSM-FIRMENICH: COMPANY OVERVIEW 
TABLE 637 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 638 DSM-FIRMENICH: PRODUCT LAUNCHES 
TABLE 639 DSM-FIRMENICH: DEALS 
TABLE 640 INGREDION: COMPANY OVERVIEW 
TABLE 641 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 642 INGREDION: PRODUCT LAUNCHES 
TABLE 643 INGREDION: DEALS 
TABLE 644 INGREDION: EXPANSIONS 
TABLE 645 TATE & LYLE: COMPANY OVERVIEW 
TABLE 646 TATE & LYLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 647 TATE & LYLE: PRODUCT LAUNCHES 
TABLE 648 TATE & LYLE: DEALS 
TABLE 649 TATE & LYLE: EXPANSIONS 
TABLE 650 AJINOMOTO CO., INC.: COMPANY OVERVIEW 
TABLE 651 AJINOMOTO CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 652 AJINOMOTO CO., INC.: DEALS 
TABLE 653 AJINOMOTO CO., INC.: EXPANSIONS 
TABLE 654 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW 
TABLE 655 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 656 ASSOCIATED BRITISH FOODS PLC: DEALS 
TABLE 657 CHR. HANSEN A/S: COMPANY OVERVIEW 
TABLE 658 CHR. HANSEN A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 659 CHR. HANSEN A/S: PRODUCT LAUNCHES AND ENHANCEMENTS 
TABLE 660 CHR. HANSEN A/S: DEALS 
TABLE 661 CHR. HANSEN A/S: EXPANSIONS 
TABLE 662 KYOWA KIRIN CO., LTD: COMPANY OVERVIEW 
TABLE 663 KYOWA KIRIN CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 664 GLANBIA PLC: COMPANY OVERVIEW 
TABLE 665 GLANBIA PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 666 GLANBIA PLC: PRODUCT LAUNCHES 
TABLE 667 GLANBIA PLC: DEALS 
TABLE 668 GLANBIA PLC: EXPANSIONS 
TABLE 669 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY OVERVIEW 
TABLE 670 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 671 FONTERRA CO-OPERATIVE GROUP LIMITED: DEALS 
TABLE 672 KERRY GROUP PLC: COMPANY OVERVIEW 
TABLE 673 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 674 KERRY GROUP PLC: PRODUCT LAUNCHES 
TABLE 675 KERRY GROUP PLC: DEALS 
TABLE 676 KERRY GROUP PLC: EXPANSIONS 
TABLE 677 DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW 
TABLE 678 DIVI'S LABORATORIES LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 679 DIVI'S LABORATORIES LIMITED: PRODUCT LAUNCHES 
TABLE 680 ROQUETTE FRÈRES: COMPANY OVERVIEW 
TABLE 681 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 682 ROQUETTE FRÈRES: PRODUCT LAUNCHES AND ENHANCEMENTS 
TABLE 683 ROQUETTE FRÈRES: EXPANSIONS 
TABLE 684 BENEO: COMPANY OVERVIEW 
TABLE 685 BENEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 686 BENEO: EXPANSIONS 
TABLE 687 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW 
TABLE 688 KEMIN INDUSTRIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 689 KEMIN INDUSTRIES, INC.: PRODUCT ENHANCEMENTS 
TABLE 690 KEMIN INDUSTRIES, INC.: EXPANSIONS 
TABLE 691 GOLDEN GRAIN GROUP LIMITED: COMPANY OVERVIEW 
TABLE 692 GOLDEN GRAIN GROUP LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 
TABLE 693 COSUCRA: COMPANY OVERVIEW 
TABLE 694 PURIS: COMPANY OVERVIEW 
TABLE 695 PROEON: COMPANY OVERVIEW 
TABLE 696 CONAGEN, INC.: COMPANY OVERVIEW 
TABLE 697 CHICKP: COMPANY OVERVIEW 
TABLE 698 ADJACENT MARKETS TO NUTRACEUTICAL INGREDIENTS MARKET 
TABLE 699 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER, 2018–2022 (USD MILLION) 
TABLE 700 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER, 2023–2028 (USD MILLION) 
TABLE 701 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 
TABLE 702 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 
TABLE 703 HEALTH INGREDIENTS MARKET, BY SOURCE, 2017–2021 (USD MILLION) 
TABLE 704 HEALTH INGREDIENTS MARKET, BY SOURCE, 2022–2027 (USD MILLION) 
TABLE 705 HEALTH INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 
TABLE 706 HEALTH INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 
  
   
LIST OF FIGURES (72 Figures)  
  
FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET: RESEARCH DESIGN 
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 
FIGURE 3 NUTRACEUTICAL INGREDIENTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 
FIGURE 4 NUTRACEUTICAL INGREDIENTS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 
FIGURE 5 SUPPLY-SIDE ANALYSIS 
FIGURE 6 DEMAND-SIDE ANALYSIS 
FIGURE 7 DATA TRIANGULATION 
FIGURE 8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 
FIGURE 9 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 
FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024 VS. 2029 (USD MILLION) 
FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET SHARE AND GROWTH RATE, BY REGION 
FIGURE 12 ADVANCES IN FOOD SCIENCE AND TECHNOLOGY AND RISING DEMAND FOR CONVENIENCE AND HEALTHY FOOD PRODUCTS TO DRIVE MARKET 
FIGURE 13 PROTEINS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT NUTRACEUTICAL INGREDIENTS MARKET SHARES IN 2024 
FIGURE 14 US TO ACCOUNT FOR LARGEST NUTRACEUTICAL INGREDIENTS MARKET SHARE IN 2024 
FIGURE 15 PROTEINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD 
FIGURE 16 FOOD SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD 
FIGURE 17 DRY SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD 
FIGURE 18 INDIA: FOOD & GROCERY IN RETAIL INDUSTRY, 2023 (USD BILLION) 
FIGURE 19 US: EMPLOYMENT STATUS OF PARENTS WITH OWN CHILDREN UNDER 18 YEARS, 2021 VS. 2022 
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: NUTRACEUTICAL INGREDIENTS MARKET 
FIGURE 21 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID 
FIGURE 22 CHRONIC DISEASES BEING ONE OF TOP TEN CAUSES OF DEATH AMONG ALL AGES (MILLION) 
FIGURE 23 NUMBER OF COUNTRIES MANDATING FOOD FORTIFICATION, 2010–2024 
FIGURE 24 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021 
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
FIGURE 26 AVERAGE SELLING PRICES OF TOP THREE TYPES, 2020–2023 (USD/KG) 
FIGURE 27 NUTRACEUTICAL INGREDIENTS MARKET: AVERAGE SELLING PRICE TREND, BY REGION (USD/KG) 
FIGURE 28 NUTRACEUTICAL INGREDIENTS MARKET: VALUE CHAIN ANALYSIS 
FIGURE 29 KEY NUTRACEUTICAL INGREDIENTS COMPANIES ECOSYSTEM 
FIGURE 30 LIST OF MAJOR PATENTS FOR NUTRACEUTICAL INGREDIENTS MARKET, 2014–2024 
FIGURE 31 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2014–2024 
FIGURE 32 EXPORT VALUE OF NUTRACEUTICAL INGREDIENTS FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND) 
FIGURE 33 IMPORT VALUE OF NUTRACEUTICAL INGREDIENTS FOR KEY COUNTRIES, 2020–2023 (USD THOUSAND) 
FIGURE 34 PORTER’S FIVE FORCES ANALYSIS: NUTRACEUTICAL INGREDIENTS MARKET 
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES 
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE TYPES 
FIGURE 37 INVESTMENT AND FUNDING SCENARIO 
FIGURE 38 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS 
FIGURE 39 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 
FIGURE 40 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS 
FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 
FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024 VS. 2029 (USD MILLION) 
FIGURE 43 BENEFITS SOUGHT FROM FOOD/BEVERAGES/NUTRIENTS IN US 
FIGURE 44 TOP SPORTS NUTRITION INGREDIENTS SOUGHT BY CONSUMERS IN EUROPE 
FIGURE 45 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 
FIGURE 46 NORTH AMERICA: MARKET SNAPSHOT 
FIGURE 47 ASIA PACIFIC: MARKET SNAPSHOT 
FIGURE 48 TOP FIVE PLAYERS DOMINATING MARKET, 2019–2023 (USD BILLION) 
FIGURE 49 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL INGREDIENTS MARKET, 2023 
FIGURE 50 RANKING OF TOP FIVE PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET, 2023 
FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (KEY NUTRACEUTICAL INGREDIENTS COMPANIES), 2023 
FIGURE 52 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY FOOTPRINT 
FIGURE 53 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 
FIGURE 54 COMPANY VALUATION OF FEW MAJOR PLAYERS (USD BILLION) 
FIGURE 55 EV/EBITDA OF KEY COMPANIES 
FIGURE 56 BRAND/PRODUCT COMPARISON 
FIGURE 57 CARGILL, INCORPORATED: COMPANY SNAPSHOT 
FIGURE 58 ADM: COMPANY SNAPSHOT 
FIGURE 59 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 
FIGURE 60 BASF SE: COMPANY SNAPSHOT 
FIGURE 61 ARLA FOODS AMBA: COMPANY SNAPSHOT 
FIGURE 62 DSM-FIRMENICH: COMPANY SNAPSHOT 
FIGURE 63 INGREDION: COMPANY SNAPSHOT 
FIGURE 64 TATE & LYLE: COMPANY SNAPSHOT 
FIGURE 65 AJINOMOTO CO., INC.: COMPANY SNAPSHOT 
FIGURE 66 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 
FIGURE 67 CHR. HANSEN A/S: COMPANY SNAPSHOT 
FIGURE 68 KYOWA KIRIN CO., LTD: COMPANY SNAPSHOT 
FIGURE 69 GLANBIA PLC: COMPANY SNAPSHOT 
FIGURE 70 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT 
FIGURE 71 KERRY GROUP PLC: COMPANY SNAPSHOT 
FIGURE 72 DIVI'S LABORATORIES LIMITED: COMPANY SNAPSHOT 

 

The study involved two major segments in estimating the current nutraceutical ingredients market size. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the nutraceutical ingredients market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the nutraceutical ingredients market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases, were referred to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key nutraceutical ingredients companies, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the nutraceutical ingredients market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors, from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to nutraceutical ingredients type, application, form, function, and region. Stakeholders from the demand side, such as food, beverages, dietary supplements, animal nutrition, and food for special purposes (FSMP) manufacturers who use the nutraceutical ingredients products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of nutraceutical ingredients and the outlook of their business which will affect the overall market.

Nutraceutical Ingredients Market Primary Research

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

Designation

ADM (US)

Sales Administrator

Associated British Foods plc (UK)

Marketing Manager

Divi's Laboratories Limited (India) 

Business Development Manager

Kemin Industries, Inc. (US)

Director (Research and Product Development)

BASF SE (Germany)

Sales & Marketing Director

Ingredion (US)

Customer Service Manager

Nutraceutical Ingredients Market Size Estimation

Both top-down and bottom-up approaches have been used to estimate and validate the total nutraceutical ingredients market size. These approaches have also been used extensively to determine the size of the various sub-segments in the market. The research methodology used to estimate the market size includes the following details:

  • The key nutraceutical ingredients companies in the industry and market have been identified through extensive secondary research.
  • The nutraceutical ingredients value chain and market size in terms of value and volume have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All macroeconomic and microeconomic factors affecting the nutraceutical ingredients market growth were considered while estimating the market size.
  • All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

Global Nutraceutical Ingredients Market: Bottom-Up Approach.

Nutraceutical Ingredients Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Nutraceutical Ingredients Market: Top-Down Approach.

Nutraceutical Ingredients Market Top Down Approach

Data Triangulation

After arriving at the overall nutraceutical ingredients market size from the estimation process explained above, the total market was split into several segments and subsegments. Data triangulation and market breakdown procedures were employed to estimate the nutraceutical ingredients market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying numerous factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.

Market Definition

There is no standard definition for nutraceutical ingredients globally, and the definition of ‘nutraceuticals’ differs in accordance with region and their industrial applications. Therefore, for the purpose of this study, nutraceutical ingredients are defined as ingredients derived from animal, plant, microbial, and synthetic sources, which provide health benefits, adding essential nutritional value and functional benefits to various applications such as food, beverages, dietary supplements, food for special medical purposes (FSMP), and animal nutrition products.

According to the FDA, nutraceuticals are ‘pharmaceutical grade’ nutrients consumed for health benefits. They are vitamins, minerals, herbs, extracts, and others.

According to the American Nutraceutical Association, the term “nutraceutical” was derived by condensing the terms “pharmaceutical and nutrition” in 1989 by Stephen DeFelice, who was the founding chairman of the Foundation for Innovation in Medicine. DeFelice suggested “a nutraceutical is any substance that is a food or a part of a food and provides medical or health benefits, including the prevention and treatment of disease. Such products may range from isolated nutrients, dietary supplements, and specific diets to genetically engineered designer foods, herbal products, and processed foods such as cereals, soups, and beverages”.

Key Stakeholders

  • Raw material suppliers
  • Manufacturers & processors of end-products, such as food, beverage, dietary supplements, feed, and food for special medical purposes (FSMP)
  • R&D laboratories
  • Nutraceutical ingredient manufacturers and suppliers
  • Nutraceutical ingredient processors
  • Food ingredient manufacturers & processors
  • Government organizations, research organizations, consulting firms, trade associations, and industry bodies
  • Regulatory bodies
    • Organizations such as the Food and Drug Administration (FDA)
    • United States Department of Agriculture (USDA)
    • European Food Safety Agency (EFSA)
    • European Union (EUROPA)
    • Codex Alimentarius
    • World Health Organization (WHO)
    • OECD-FAO Agricultural Outlook
    • Food Safety Australia and New Zealand (FSANZ)
  • Intermediary suppliers such as traders, distributors, and suppliers of ingredients and end products

Report Objectives

  • Determining and projecting the nutraceutical ingredients market size, with respect to type, application, form, function (qualitative), and region, over five years, ranging from 2024 to 2029
  • Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments across key regions
  • Analyzing the demand-side factors based on the following:
    • Impact of macro- and micro-economic factors on the market
    • Shifts in demand patterns across different subsegments and regions
  • Providing detailed information about the key factors influencing the nutraceutical ingredients market growth (drivers, restraints, opportunities, and industry-specific challenges)

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of European market for nutraceutical ingredients into Poland, the Netherlands, Belgium, and other EU and non-EU countries.
  • Further breakdown of the Rest of Asia Pacific market for nutraceutical ingredients into South Korea and ASEAN countries such as Vietnam, Indonesia, Malaysia, the Philippines, Thailand, and Singapore.
  • Further breakdown of the Rest of South American market for nutraceutical ingredients into Colombia, Chile, and Peru.
  • Further breakdown of the Rest of the World into the Middle East and Africa.

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
FB 2211
Published ON
Jul, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Ingredients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Hold On!

Want to explore hidden markets that can drive new revenue in Nutraceutical Ingredients Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback